HOME >> BIOLOGY >> NEWS
Vanderbilt's John Oates wins clinical research award

John A. Oates Jr., M.D., Thomas F. Frist Sr. Professor of Medicine and professor of Pharmacology at Vanderbilt University Medical Center, received the Sixteenth Annual Award of Excellence in Clinical Research from the General Clinical Research Centers Program April 17.

The award acknowledges outstanding clinical research, supported by the National Center for Research Resources of the National Institutes of Health.

The $5,000 award and certificate was conferred during the General Clinical Research Centers Program Directors meeting in Chicago. At the meeting, Oates delivered a lecture titled "Investigation on the Contribution of Cyclooxygenases to Human Disease."

"Dr. Oates is a legend in Clinical Research. He put Vanderbilt's clinical research on the map, and I was personally excited to propose him for this award, and gratified that others recognized, as we do, his enormous contributions," said Alastair Wood, M.D., associate dean of external affairs at Vanderbilt.

"There are several important features or characteristics of Vanderbilt that nurtured the research that went on here -- the intent of Vanderbilt Pharmacology to include human pharmacology within the scope of the academic mission of the department," Oates said. "Their commitment to it has brought strong basic science to bear on our clinical research. For the investigation of human pharmacology, this has been an ideal setting."

Oates said the Vanderbilt General Clinical Research Center has been recognized as one of the leading GCRC's in the United States, and a great asset to the Medical School.

"The General Clinical Research Center has provided essential resources for our research, initially under the leadership of Elliot Newman, and more recently, David Robertson," Oates said.

"Recently NIH leadership has rediscovered the importance of patient-oriented research and has taken a number of helpful steps to support it," Robertson said. "As attention has focused on the na
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
19-Apr-2004


Page: 1 2

Related biology news :

1. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
2. Matrisian named Vanderbilts first chair of cancer biology
3. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Innovative ceramic-on-metal hip replacements to undergo clinical trials
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. Warren Pharmaceuticals publishes results of preclinical evaluation
8. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
9. Scientists characterize new breast tumor subtypes with poor clinical outcomes
10. Uncertainty in clinical tests raises health care costs
11. Germany starts clinical development of a new tuberculosis vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North Carolina, ... Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of the ...
Breaking Biology Technology:
Cached News: